Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 543-548, February 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dricu, A.
Right arrow Articles by Larsson, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dricu, A.
Right arrow Articles by Larsson, O.

Inhibition of N-linked Glycosylation Using Tunicamycin Causes Cell Death in Malignant Cells: Role of Down-Regulation of the Insulin-like Growth Factor 1 Receptor in Induction of Apoptosis1

Anica Dricu, Magdalena Carlberg, Min Wang and Olle Larsson2

Department of Tumor Pathology, Karolinska Institutet, S-17177, Stockholm, Sweden

Recent studies have shown that inhibition of N-linked glycosylation using tunicamycin (TM) induces cell death in cultured cells (O. Larsson et al., J. Cell Sci., 106: 299–307, 1993; J. Y. Chang and V. Korolev, Exp. Neurol., 137: 201–211, 1996). The mechanisms underlying TM-induced cell death seem, however, to be complex in nature. In SV40-transformed cells, TM triggers within a few minutes mechanisms subsequently leading to apoptosis. These mechanisms, although still not fully understood, involve an elevation of [Ca2+]i (M. Carlberg et al., Carcinogenesis, 17: 2589–2596, 1996). In contrast, in melanoma cells, TM has to be present continuously for 24–48 h to elicit apoptosis. Before the appearance of apoptotic melanoma cells, assayed by gel-electrophoretic detection of oligonucleosomally fragmented DNA, the binding of insulin-like growth factor I (IGF-I) to the cells had become drastically decreased, which in turn was found to be due to down-regulation of IGF-I receptor proteins at the cell surface. Incubation of the cells with an antibody ({alpha}IR-3) against the IGF-I-binding site of the receptor resulted also in apoptosis, the kinetics of which were almost identical to those following treatment with TM. Furthermore, coincubation of a high concentration of IGF-I (50 ng/ml) with TM totally rescued the melanoma cells from apoptotic cell death during the first 48 h after addition of the drugs. This effect was shown to be abolished fully by {alpha}IR-3. Taken together, our data suggest strongly that N-linked glycosylation plays an important role in maintenance of viability of melanoma cells through regulating the translocation of IGF-I receptor to the cell surface.

1 This project was supported by grants from the Swedish Cancer Society, the Cancer Society in Stockholm, and the Karolinska Institute.

2 To whom requests for reprints should be addressed. Fax: +46 8 321047.

Received 8/19/96. Accepted 12/ 2/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. N. Contessa, M. S. Bhojani, H. H. Freeze, A. Rehemtulla, and T. S. Lawrence
Inhibition of N-Linked Glycosylation Disrupts Receptor Tyrosine Kinase Signaling in Tumor Cells
Cancer Res., May 15, 2008; 68(10): 3803 - 3809.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Ahlen, J. Wejde, O. Brosjo, A. von Rosen, W.-H. Weng, L. Girnita, O. Larsson, and C. Larsson
Insulin-Like Growth Factor Type 1 Receptor Expression Correlates to Good Prognosis in Highly Malignant Soft Tissue Sarcoma
Clin. Cancer Res., January 1, 2005; 11(1): 206 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Lee, L. Neigeborn, and R. J. Kaufman
The Unfolded Protein Response Is Required for Haploid Tolerance in Yeast
J. Biol. Chem., March 28, 2003; 278(14): 11818 - 11827.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. All-Ericsson, L. Girnita, S. Seregard, A. Bartolazzi, M. J. Jager, and O. Larsson
Insulin-like Growth Factor-1 Receptor in Uveal Melanoma: A Predictor for Metastatic Disease and a Potential Therapeutic Target
Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Ito, P. Pandey, N. Mishra, S. Kumar, N. Narula, S. Kharbanda, S. Saxena, and D. Kufe
Targeting of the c-Abl Tyrosine Kinase to Mitochondria in Endoplasmic Reticulum Stress-Induced Apoptosis
Mol. Cell. Biol., September 15, 2001; 21(18): 6233 - 6242.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Girnita, A. Girnita, B. Brodin, Y. Xie, G. Nilsson, A. Dricu, J. Lundeberg, J. Wejde, A. Bartolazzi, K. G. Wiman, et al.
Increased Expression of Insulin-like Growth Factor I Receptor in Malignant Cells Expressing Aberrant p53: Functional Impact
Cancer Res., September 1, 2000; 60(18): 5278 - 5283.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Y. Xie, B. Skytting, G. Nilsson, B. Brodin, and O. Larsson
Expression of Insulin-like Growth Factor-1 Receptor in Synovial Sarcoma: Association with an Aggressive Phenotype
Cancer Res., August 1, 1999; 59(15): 3588 - 3591.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. J. Kaufman
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls
Genes & Dev., May 15, 1999; 13(10): 1211 - 1233.
[Full Text]


Home page
Genes Dev.Home page
H. Zinszner, M. Kuroda, X. Wang, N. Batchvarova, R. T. Lightfoot, H. Remotti, J. L. Stevens, and D. Ron
CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum
Genes & Dev., April 1, 1998; 12(7): 982 - 995.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.